New study sees if Real-World data can track Lecanemab's impact on families
NCT ID NCT06285448
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test whether it's possible to create a registry for people with Alzheimer's who are receiving lecanemab infusions, along with their care partners. Researchers want to see if they can collect information on quality of life and caregiver burden in a real-world clinic setting. The study will enroll 20 people and their care partners at HealthPartners clinics.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
lecanemab
What this could lead to
If successful, this registry could help researchers understand how lecanemab affects daily life for people with Alzheimer's and their caregivers in real-world settings.
What could go wrong
This is a very small feasibility study (20 people) focused on data collection, not on proving the drug works. It may not lead to broader conclusions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
HealthPartners Neuroscience Center
Saint Paul, Minnesota, 55130, United States